Pentoxifylline 400 mg Tablet

PENTOXIFYLLINE 400 MG is a clinically proven hemorrheologic agent designed to restore mobility and comfort in patients with Intermittent Claudication and Peripheral Artery Disease (PAD). Unlike standard vasodilators, Pentoxifylline targets the blood’s physical properties—reducing viscosity and increasing red blood cell flexibility—to allow oxygen-rich blood to bypass narrowed arteries. This advanced therapeutic action enables patients to walk further, remain active, and reduce the painful cramping and numbness associated with restricted circulation.

• Active Ingredient: Pentoxifylline 400 mg (Extended-Release)

• Pharmacological Class: Xanthine Derivative / Hemorrheologic Agent

• Reference Brands: Trental®, Pentoxil®, Flexital®

• Main Indication: Chronic occlusive arterial disease of the limbs.

• Quality Assurance: WHO-GMP certified batches with 2026/2027 expiry.

⚠️ Medical Disclaimer

This information is for educational purposes only. Pentoxifylline is a Prescription-Only Medicine (POM). Diagnosis and treatment must be managed by a licensed healthcare provider. We strictly verify all prescriptions before dispatch to ensure patient safety and global regulatory compliance.

How it works

In 2026, clinical guidelines continue to recognize Pentoxifylline as a vital therapy for patients needing micro-circulatory support without the risks of heavy anticoagulants.

• Micro-Circulation Optimization: It increases the "deformability" of red blood cells, allowing them to squeeze through oxygen-starved capillaries.

• Viscosity Reduction: Lowers plasma fibrinogen levels, effectively making the blood "thinner" and easier for the heart to pump.

• Vascular Protection: Reduces platelet aggregation, minimizing the risk of micro-clots in the extremities.

• Sustained-Release Stability: The 400 mg ER formulation ensures a stable 12-hour therapeutic window, preventing the gastric irritation associated with standard tablets.

To ensure maximum efficacy and minimize side effects, strict adherence to pharmaceutical protocols is required.

• Standard Dose: One 400 mg tablet, three times daily (TID).

• Administration: Always take with food to prevent gastrointestinal upset.

• Important: DO NOT CRUSH. The tablet must be swallowed whole. Breaking or chewing the tablet destroys the extended-release coating, leading to potential toxicity and immediate gastric irritation.

• Clinical Timeline: Initial relief may occur in 2–4 weeks; however, full clinical benefit is reached at 8 weeks of consistent use.